Aims & Scope
The European Journal of Cancer is a peer-reviewed, open access oncology journal published by Directive Publications, dedicated to advancing clinical, translational, and surgical cancer research. The journal serves oncologists, hematologists, surgical and radiation oncologists, cancer biologists, and translational scientists with rigorous, internationally accessible scholarship across the cancer continuum, from molecular pathogenesis to diagnosis, treatment, and survivorship.
We welcome original research, systematic reviews and meta-analyses, case reports, and editorials spanning tumor biology, cancer biomarkers and liquid biopsy (circulating tumor DNA, cell-free DNA, microRNAs), molecular cytogenetics, hematological malignancies (multiple myeloma, DLBCL and other lymphomas), surgical and interventional oncology, pediatric oncology, translational pharmacology including phytochemical and inflammasome research, and emerging artificial intelligence applications in cancer screening and diagnostics.
Every submission undergoes double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright.
The journal adheres to COPE ethical principles and supports global research equity through article-processing-charge waivers and discounts, ensuring authors from all regions can disseminate high-impact cancer research to a worldwide readership.
Subject Coverage
The European Journal of Cancer welcomes original research, reviews, and case reports across the following core areas:
Research Topics
Core subject areas published in The European Journal of Cancer — explore related research across our journals.
Articles
Comparative Study Of Breast Conserving Surgery And Modified Radical Mastectomy In Patients With Breast Cancer At A Tertiary Cancer Centre
The Dynamics of breast cancer among patients attending a Teaching Hospital in Nigeria
Prognostic value of circulating tumor DNA (ctDNA) in Diffuse Large B-Cell Lymphoma (DLBCL): Systemic review and meta-analysis
Curcumin–Thymoquinone Complex (CTQ) in Mitochondrial Resilience and Inflammasome Regulation: A Translational Review
Comparative analysis of preoperative and postoperative findings in patients with endometrial hyperplasia: a clinical study
Clinical Indicators of Breast Cancer Relapse: An Observational Review
Chemotherapy Approaches in the Treatment of Childhood Retinoblastoma: Comparison of Intravenous, Intra-arterial and Intravitreal Therapies
An Overview of the Psychological and Emotional Challenges of Lymphedema in Breast Cancer Patients
Advances in In-Silico Analysis of Bioactive Compounds: Metabolic Interactions with genes involved in Prostate Cancer
A Comprehensive Meta-analysis of Robotic Duodenopancreatectomy versus Laparoscopic Duodenopancreatectomy for Adenocarcinoma of the Head of the Pancreas
Editorial Board
Peer review for this journal is governed under COPE principles by an editorial board of 5 members.
View Editorial Board (5) →Frequently Asked Questions
What topics does The European Journal of Cancer cover?
The European Journal of Cancer publishes oncology research across the cancer continuum: tumor biology, cancer biomarkers and liquid biopsy (circulating tumor DNA, cell-free DNA, microRNAs), molecular cytogenetics, hematological malignancies such as multiple myeloma and DLBCL, surgical and interventional oncology, pediatric oncology, translational pharmacology including phytochemicals, and AI-driven cancer screening and diagnostics.
Who should publish in or read The European Journal of Cancer?
The journal is intended for oncologists, hematologists, surgical and radiation oncologists, cancer biologists, translational researchers, pathologists, and clinical scientists seeking peer-reviewed, open access cancer research.
How do I submit a manuscript to The European Journal of Cancer?
Authors submit through the Directive Publications submission system. The journal accepts original research, systematic reviews and meta-analyses, case reports, and editorials in oncology. Manuscripts should follow the author guidelines for formatting, ethics declarations, and reporting standards before submission.
What article types does The European Journal of Cancer accept?
The European Journal of Cancer accepts original research articles, systematic reviews and meta-analyses, narrative and translational reviews, clinical and surgical case reports, observational studies, and editorials addressing clinical, translational, and surgical oncology.
Is The European Journal of Cancer open access, and does it use peer review?
Yes. Every article is published open access under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright. All submissions undergo rigorous double-blind peer review.
Are there article-processing charges or waivers for The European Journal of Cancer?
As an open access oncology journal, an article-processing charge applies on acceptance to sustain peer review, production, and permanent hosting. Waivers and discounts are available to support authors with limited funding, particularly from low- and middle-income settings; contact the editorial office for current terms.
How does The European Journal of Cancer differ from established cancer journals?
The journal welcomes translational and surgical oncology, liquid-biopsy biomarker studies, and emerging AI-in-oncology work, providing global authors an accessible venue with equity-focused APC waivers.